Achyut Healthcare Board of Directors

Get the latest insights into the leadership at Achyut Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Mahendra Chatrabhuj Raycha Chairman & Non-Exe.Director
Mr. Jigen Jagdishbhai Modi Managing Director
Ms. Amisha Jigen Modi Executive Director
Mr. Akshit Mahendra Raycha Non Executive Director
Mr. Rutvik Sanjaykumar Thakkar Independent Director
Mrs. Sonu Lalitkumar Jain Independent Director

Achyut Healthcare Share price

ACHYUT

5.34

0.15 (2.89%)
Last updated on 4 Sep, 2025 | 12:47 IST
BUYSELL
Today's High

5.38

Today's Low

5.17

52 Week Low

2.82

52 Week High

6.25

The current prices are delayed, login to your account for live prices

Achyut Healthcare FAQs

The board at Achyut Healthcare consists of experienced professionals, including Mr. Mahendra Chatrabhuj Raycha , Mr. Jigen Jagdishbhai Modi , and others, overseeing the company’s strategic and corporate governance.

Directors at Achyut Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Mahendra Chatrabhuj Raycha is the current chairman at Achyut Healthcare.

Executive directors at Achyut Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Achyut Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Achyut Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.